OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
EAACI Biologicals Guidelines—Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old
Ioana Agache, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Allergy (2021) Vol. 77, Iss. 1, pp. 17-38
Open Access | Times Cited: 33
Ioana Agache, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Allergy (2021) Vol. 77, Iss. 1, pp. 17-38
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
Urticaria
Pavel Kolkhir, Ana M. Giménez‐Arnau, Kanokvalai Kulthanan, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 209
Pavel Kolkhir, Ana M. Giménez‐Arnau, Kanokvalai Kulthanan, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 209
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
Pavel Kolkhir, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 743-767
Closed Access | Times Cited: 67
Pavel Kolkhir, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 743-767
Closed Access | Times Cited: 67
Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
Thomas B. Casale, Ana M. Giménez‐Arnau, Jonathan A. Bernstein, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 11, pp. 2573-2588
Open Access | Times Cited: 17
Thomas B. Casale, Ana M. Giménez‐Arnau, Jonathan A. Bernstein, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 11, pp. 2573-2588
Open Access | Times Cited: 17
Long-Term Safety of Omalizumab in Children with Asthma and/or Chronic Spontaneous Urticaria: A 4-Year Prospective Study in Real Life
Francesca Galletta, Lucia Caminiti, Cecilia Lugarà, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 7, pp. 1068-1068
Open Access | Times Cited: 14
Francesca Galletta, Lucia Caminiti, Cecilia Lugarà, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 7, pp. 1068-1068
Open Access | Times Cited: 14
Controversies in Allergy: Choosing a Biologic for Patients with Severe Asthma
Ian Pavord, Nicola A. Hanania, Jonathan Corren
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 10, Iss. 2, pp. 410-419
Closed Access | Times Cited: 30
Ian Pavord, Nicola A. Hanania, Jonathan Corren
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 10, Iss. 2, pp. 410-419
Closed Access | Times Cited: 30
Ligelizumab impairs IgE ‐binding to plasmacytoid dendritic cells more potently than omalizumab and restores IFN ‐α production and FOXP3 + Treg generation
Cristina Benito‐Villalvilla, Andrés de la Rocha‐Muñoz, Jacobo López‐Abente, et al.
Allergy (2022) Vol. 78, Iss. 4, pp. 1060-1072
Open Access | Times Cited: 19
Cristina Benito‐Villalvilla, Andrés de la Rocha‐Muñoz, Jacobo López‐Abente, et al.
Allergy (2022) Vol. 78, Iss. 4, pp. 1060-1072
Open Access | Times Cited: 19
A retrospective analysis of factors influencing response to omalizumab treatment in Indian patients with antihistamine refractory chronic spontaneous urticaria
Thammannagowda Prarthana, Hitaishi Mehta, Anuradha Bishnoi, et al.
Asia Pacific Allergy (2025)
Open Access
Thammannagowda Prarthana, Hitaishi Mehta, Anuradha Bishnoi, et al.
Asia Pacific Allergy (2025)
Open Access
Systemtherapie bei allergologischen Erkrankungen
Petra Staubach, Yalda Ghoreishi, Nicola Wagner
Deleted Journal (2025)
Closed Access
Petra Staubach, Yalda Ghoreishi, Nicola Wagner
Deleted Journal (2025)
Closed Access
Omalizumab in Chronic Spontaneous Urticaria (CSU): Real-Life Experience in Dose/Interval Adjustments and Treatment Discontinuation
Rita Brás, Célia Costa, Rita Limão, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 8, pp. 2392-2402
Closed Access | Times Cited: 10
Rita Brás, Célia Costa, Rita Limão, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 8, pp. 2392-2402
Closed Access | Times Cited: 10
Disparities in chronic spontaneous urticaria: Eligibility for drug reimbursement associated with clinical outcomes
Hugo W.F. Mak, Valerie Chiang, Elsie T.S. Chan, et al.
Journal of Allergy and Clinical Immunology Global (2024) Vol. 3, Iss. 2, pp. 100243-100243
Open Access | Times Cited: 3
Hugo W.F. Mak, Valerie Chiang, Elsie T.S. Chan, et al.
Journal of Allergy and Clinical Immunology Global (2024) Vol. 3, Iss. 2, pp. 100243-100243
Open Access | Times Cited: 3
Systematic Review and Critical Appraisal of Urticaria Clinical Practice Guidelines: A Global Guidelines in Dermatology Mapping Project (GUIDEMAP)
Hsi Yen, Hsuan Yen, Chun‐Hsien Huang, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 10, pp. 3213-3220.e11
Closed Access | Times Cited: 8
Hsi Yen, Hsuan Yen, Chun‐Hsien Huang, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 10, pp. 3213-3220.e11
Closed Access | Times Cited: 8
Evaluation of Pediatric Chronic Urticaria with Emphasis on Clinical and Laboratory Characteristics and Treatment Response to Omalizumab: A Real-Life Experience from a Tertiary Allergy Center
Aylin KONT ÖZHAN, Tugba Arıkoğlu
Children (2024) Vol. 11, Iss. 1, pp. 86-86
Open Access | Times Cited: 2
Aylin KONT ÖZHAN, Tugba Arıkoğlu
Children (2024) Vol. 11, Iss. 1, pp. 86-86
Open Access | Times Cited: 2
Characterization of omalizumab updosing patterns and predictive factors in chronic spontaneous urticaria: A prospective multicentric observational study
Guillaume Pierrard, Claire Bernier, A. Du‐Thanh, et al.
Allergy (2024) Vol. 79, Iss. 9, pp. 2448-2457
Open Access | Times Cited: 2
Guillaume Pierrard, Claire Bernier, A. Du‐Thanh, et al.
Allergy (2024) Vol. 79, Iss. 9, pp. 2448-2457
Open Access | Times Cited: 2
Immunopathogenesis of urticaria: a clinical perspective on histamine and cytokine involvement
Rudranil Bhowmik, Md. Adil Shaharyar, Arnab Sarkar, et al.
Inflammation Research (2024) Vol. 73, Iss. 5, pp. 877-896
Closed Access | Times Cited: 2
Rudranil Bhowmik, Md. Adil Shaharyar, Arnab Sarkar, et al.
Inflammation Research (2024) Vol. 73, Iss. 5, pp. 877-896
Closed Access | Times Cited: 2
Eosinophilic granulomatous polyangiitis with central nervous system involvement in children: a case report and literature review
Nana Nie, Lin Liu, Cui Bai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Nana Nie, Lin Liu, Cui Bai, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Comparative efficacy and safety of the treatment by Omalizumab for chronic idiopathic urticaria in the general population: A systematic review and network meta‐analysis
Lan Xu, Yu Han, Shengxian Xu, et al.
Skin Research and Technology (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 2
Lan Xu, Yu Han, Shengxian Xu, et al.
Skin Research and Technology (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 2
Efficacy of Different Dosing Regimens of IgE Targeted Biologic Omalizumab for Chronic Spontaneous Urticaria in Adult and Pediatric Populations: A Meta-Analysis
Humayun Manzoor, Foha Razi, Amina Rasheed, et al.
Healthcare (2022) Vol. 10, Iss. 12, pp. 2579-2579
Open Access | Times Cited: 10
Humayun Manzoor, Foha Razi, Amina Rasheed, et al.
Healthcare (2022) Vol. 10, Iss. 12, pp. 2579-2579
Open Access | Times Cited: 10
Allergen immunotherapy: progress and future outlook
Lara Šošić, Marta Paolucci, Stephan Flory, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 7, pp. 745-769
Closed Access | Times Cited: 5
Lara Šošić, Marta Paolucci, Stephan Flory, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 7, pp. 745-769
Closed Access | Times Cited: 5
Pediatric chronic spontaneous urticaria: a brief clinician’s guide
Martina Votto, Giovanna Achilli, Maria De Filippo, et al.
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 9, pp. 889-899
Closed Access | Times Cited: 6
Martina Votto, Giovanna Achilli, Maria De Filippo, et al.
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 9, pp. 889-899
Closed Access | Times Cited: 6
Efficacy and safety of omalizumab against chronic spontaneous urticaria: Real-world study from China
Ao Wang, Yuhui Yun, Zhihua Wen, et al.
World Allergy Organization Journal (2022) Vol. 15, Iss. 12, pp. 100719-100719
Open Access | Times Cited: 5
Ao Wang, Yuhui Yun, Zhihua Wen, et al.
World Allergy Organization Journal (2022) Vol. 15, Iss. 12, pp. 100719-100719
Open Access | Times Cited: 5
Effects of omalizumab combined with budesonide formoterol on clinical efficacy, pulmonary function, immune function, and adverse reactions in children with moderate and severe allergic asthma
Fuzhe Chen, Lei Liang, Fang Fang Chu, et al.
Allergologia et Immunopathologia (2023) Vol. 51, Iss. 4, pp. 182-188
Open Access | Times Cited: 2
Fuzhe Chen, Lei Liang, Fang Fang Chu, et al.
Allergologia et Immunopathologia (2023) Vol. 51, Iss. 4, pp. 182-188
Open Access | Times Cited: 2
Mapping the intellectual structure of the research of omalizumab in chronic spontaneous urticaria: A bibliometric analysis
Yuxu Yao, Zhichen Liu, Jiang Ji, et al.
Journal of Allergy and Clinical Immunology Global (2024) Vol. 3, Iss. 2, pp. 100222-100222
Open Access
Yuxu Yao, Zhichen Liu, Jiang Ji, et al.
Journal of Allergy and Clinical Immunology Global (2024) Vol. 3, Iss. 2, pp. 100222-100222
Open Access
Chronic Urticaria in Pregnancy: Physiologic and Hormonal Background for an Immune Skin Disease
Abbas Khalili, Bamdad Sadeghi
Journal of South Asian Federation of Obstetrics and Gynaecology (2024) Vol. 16, Iss. 2, pp. 145-149
Open Access
Abbas Khalili, Bamdad Sadeghi
Journal of South Asian Federation of Obstetrics and Gynaecology (2024) Vol. 16, Iss. 2, pp. 145-149
Open Access
Real-World Effectiveness of Omalizumab in Chronic Urticaria: A Clinical Observational Study
Fan Zhang, Jiashun Liao, Qian Yuan, et al.
International Archives of Allergy and Immunology (2024) Vol. 185, Iss. 7, pp. 718-728
Open Access
Fan Zhang, Jiashun Liao, Qian Yuan, et al.
International Archives of Allergy and Immunology (2024) Vol. 185, Iss. 7, pp. 718-728
Open Access
Clinical efficacy of Zhiyang Xiaozhen granules combined with second-generation antihistamine in the treatment of chronic urticaria.
Li Zhang, Bo Yang, Qiaozhi Cao, et al.
PubMed (2024) Vol. 49, Iss. 2, pp. 175-181
Closed Access
Li Zhang, Bo Yang, Qiaozhi Cao, et al.
PubMed (2024) Vol. 49, Iss. 2, pp. 175-181
Closed Access
